N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
US8846675B2 · kind B2 · utility
0Cited by
26References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2012 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | May 3, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.